mignificent personal page - To The Moon

mignificent

mignificent

No personal profile

3Follow

0Followers

0Topic

0Badge

2021-07-22

More to come ??

Microsoft rose over 1%, reaching record high

2021-07-22

More to come for rising stock ??

Sorry, the original content has been removed

2021-07-22

Pls cmon coke, boa? ?

Warren Buffett Has Gained Over $181 Billion on These 5 Stocks

2021-06-26

Interesting ?

Sorry, the original content has been removed

2021-07-22

Still in uncertainty for sure ?

What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning

2021-07-06

Canabis stock ?

2021-07-06

Interesting news

Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly

2021-06-26

Interesting

Netflix Rises as Credit Suisse Sees Subscriber Growth Normalizing

2021-06-26

RPA stock

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4087620081913390","uuid":"4087620081913390","gmtCreate":1624517524503,"gmtModify":1625625360547,"name":"mignificent","pinyin":"mignificent","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.04","exceedPercentage":"60.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":172221780,"gmtCreate":1626963213840,"gmtModify":1703481498758,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Still in uncertainty for sure ?","listText":"Still in uncertainty for sure ?","text":"Still in uncertainty for sure ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172221780","repostId":"2153673800","repostType":4,"repost":{"id":"2153673800","pubTimestamp":1626958140,"share":"https://ttm.financial/m/news/2153673800?lang=&edition=fundamental","pubTime":"2021-07-22 20:49","market":"us","language":"en","title":"What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2153673800","media":"Motley Fool","summary":"It shouldn't impact the healthcare giant very much.","content":"<p>Three months ago, the Food and Drug Administration placed a warning on the label for <b>Johnson &amp; Johnson</b>'s (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the regulator added another. In this <i>Motley Fool Live</i> video <b>recorded on July 14, 2021</b>, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning.</p>\n<p><b>Keith Speights:</b> Let's move on to another company that's in the news with COVID-19. The FDA has added a new warning to Johnson &amp; Johnson's COVID-19 vaccine, and this is related to a very rare neurological disorder. Brian, what's the potential issue here, and does this impact in any way Johnson &amp; Johnson's ability to market its vaccine?</p>\n<p><b>Brian Orelli:</b> The syndrome is called Guillain-Barre syndrome. It's characterized by numbness at the extremities. Most people recover, but it can lead to full-body paralysis. There has been about 100 cases in the 12 million people who have been vaccinated, and about half of those are coming in men 50 or older, so that seems to be the population that might be most susceptible.</p>\n<p>But if I did the math correctly, I think it's 0.0008% chance of getting this syndrome, so I don't think it's really a major issue. I think the warning by the FDA is probably more for doctors to be able to identify, know that it's happening in a very small number of people, and then they can treat it accordingly.</p>\n<p>I think that's probably the main take-home point here is that it's not a major issue, and I don't that it's going to affect sales of Johnson &amp; Johnson's vaccine in any sort of material way.</p>\n<p><b>Speights:</b> I would totally agree with you there, and it's not going to impact Johnson &amp; Johnson from an investing standpoint probably at all. The vaccine is still only a really small percentage of this company's total sales. Johnson &amp; Johnson is a healthcare giant, the biggest healthcare company in the world.</p>\n<p>My concern on this is doesn't have anything to do with Johnson &amp; Johnson actually. My only concern about this is it's just <a href=\"https://laohu8.com/S/AONE.U\">one</a> other thing for the remaining segment of Americans who are reluctant to take a vaccine, it's just one more thing to make them a little worried.</p>\n<p>Even though like you said, this is an extremely rare occurrence, it's one more thing for people who didn't want to take a vaccine in the first place to say, \"Ah yeah, they found something else with one of these vaccines.\"</p>\n<p><b>Orelli:</b> But your risk of dying from COVID is a lot worse than your risk of getting this disease that may just clear up on its own. I think that that's the message that the government has to get through to people that are on the fence and are not wanting to get the vaccine. But I think it's a difficult proposition to make.</p>\n<p><b>Speights:</b> Exactly. Of course, if anyone has ever watched a TV commercial promoting a prescription drug of any kind, you are going to note the announcer is going to -- very hastily, I might add -- read off a long list of potential side effects.</p>\n<p>I don't know that there's a drug or vaccine out there that doesn't have some type of potential side effect. But most of them are rare, and in this case, extremely rare. This isn't a big deal, in general. But again, my concern is there are folks out there who are looking for reasons not to take a vaccine.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-22 20:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Three months ago, the Food and Drug Administration placed a warning on the label for Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153673800","content_text":"Three months ago, the Food and Drug Administration placed a warning on the label for Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the regulator added another. In this Motley Fool Live video recorded on July 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning.\nKeith Speights: Let's move on to another company that's in the news with COVID-19. The FDA has added a new warning to Johnson & Johnson's COVID-19 vaccine, and this is related to a very rare neurological disorder. Brian, what's the potential issue here, and does this impact in any way Johnson & Johnson's ability to market its vaccine?\nBrian Orelli: The syndrome is called Guillain-Barre syndrome. It's characterized by numbness at the extremities. Most people recover, but it can lead to full-body paralysis. There has been about 100 cases in the 12 million people who have been vaccinated, and about half of those are coming in men 50 or older, so that seems to be the population that might be most susceptible.\nBut if I did the math correctly, I think it's 0.0008% chance of getting this syndrome, so I don't think it's really a major issue. I think the warning by the FDA is probably more for doctors to be able to identify, know that it's happening in a very small number of people, and then they can treat it accordingly.\nI think that's probably the main take-home point here is that it's not a major issue, and I don't that it's going to affect sales of Johnson & Johnson's vaccine in any sort of material way.\nSpeights: I would totally agree with you there, and it's not going to impact Johnson & Johnson from an investing standpoint probably at all. The vaccine is still only a really small percentage of this company's total sales. Johnson & Johnson is a healthcare giant, the biggest healthcare company in the world.\nMy concern on this is doesn't have anything to do with Johnson & Johnson actually. My only concern about this is it's just one other thing for the remaining segment of Americans who are reluctant to take a vaccine, it's just one more thing to make them a little worried.\nEven though like you said, this is an extremely rare occurrence, it's one more thing for people who didn't want to take a vaccine in the first place to say, \"Ah yeah, they found something else with one of these vaccines.\"\nOrelli: But your risk of dying from COVID is a lot worse than your risk of getting this disease that may just clear up on its own. I think that that's the message that the government has to get through to people that are on the fence and are not wanting to get the vaccine. But I think it's a difficult proposition to make.\nSpeights: Exactly. Of course, if anyone has ever watched a TV commercial promoting a prescription drug of any kind, you are going to note the announcer is going to -- very hastily, I might add -- read off a long list of potential side effects.\nI don't know that there's a drug or vaccine out there that doesn't have some type of potential side effect. But most of them are rare, and in this case, extremely rare. This isn't a big deal, in general. But again, my concern is there are folks out there who are looking for reasons not to take a vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172220563,"gmtCreate":1626963122352,"gmtModify":1703481494717,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Pls cmon coke, boa? ?","listText":"Pls cmon coke, boa? ?","text":"Pls cmon coke, boa? ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172220563","repostId":"2153787206","repostType":4,"repost":{"id":"2153787206","pubTimestamp":1627011840,"share":"https://ttm.financial/m/news/2153787206?lang=&edition=fundamental","pubTime":"2021-07-23 11:44","market":"us","language":"en","title":"Warren Buffett Has Gained Over $181 Billion on These 5 Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2153787206","media":"Motley Fool","summary":"These five holdings account for 88% of Berkshire Hathaway's unrealized gains.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of Omaha has led his stock to an average annual return of 20%. Taking into account the 20% year-to-date gain for Berkshire's Class A shares (BRK.A), shareholders have seen Buffett generate aggregate returns of almost 3,400,000% in 56 years.</p>\n<p>Although Berkshire Hathaway has a relatively large portfolio filled with four dozen different securities, Buffett has never been a big fan of diversification. As a result, only a small number of holdings comprise the bulk of Berkshire Hathaway's $206.4 billion in unrealized gains, as of this past weekend.</p>\n<p>Based on the cost basis of Berkshire's major holdings (outlined in the company's 2020 annual shareholder letter), the following five stocks have netted Buffett $181.1 billion in combined unrealized gains (about 88% of all current unrealized profit), not including dividends paid.</p>\n<p><img src=\"https://static.tigerbbs.com/d28b3a8823057ce2bc2495cefe7ee3ff\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Berkshire Hathaway CEO Warren Buffett is all smiles with his company sitting on over $206 billion in unrealized gains. Image source: The Motley Fool.</p>\n<h3>Apple: $101,764,676,001 in unrealized gains</h3>\n<p>Easily the best investment of Buffett's tenured career is <b>Apple</b> (NASDAQ:AAPL). Even after modestly paring down his company's stake in the tech kingpin, Berkshire Hathaway still owns 907,559,761 shares at a cost basis of $34.26 a share. With Apple closing last week at $146.39 a share, the Oracle of Omaha and his team are sitting on close to a $102 billion unrealized gain.</p>\n<p>Investors certainly shouldn't look for this stake to be reduced any further anytime soon. That's because Buffett views Apple as Berkshire Hathaway's \"third business.\" It's a globally recognized brand with an exceptionally loyal following, as evidenced by the mammoth lines outside of its stores anytime a new product hits the shelves. And, as you're probably aware, the iPhone is the dominant smartphone by market share in the U.S.</p>\n<p>In addition to Apple being a product innovation juggernaut, CEO Tim Cook is overseeing a steady transition toward services. By emphasizing various subscription-based platforms, Apple can reduce some of the revenue lumpiness associated with tech replacement cycles and likely boost its operating margins.</p>\n<p>A final reason Buffett isn't bailing on Apple is the company's generous shareholder return program. Though some of you might be scratching your head given that Apple's dividend yield is \"only\" 0.6%, the $0.88 base annual payout is closer to 2.6% of Berkshire Hathaway's cost basis. Tack on Apple's aggressive share repurchase program and you have a very shareholder-friendly company.</p>\n<p><img src=\"https://static.tigerbbs.com/44a30c4dfd6886a29e22d3c6558c3e56\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Bank of America: $24,530,235,143 in unrealized gains</h3>\n<p>There's no industry on the planet Buffett loves more than bank stocks -- and there's no bank stock Buffett favors more than <b>Bank of America</b> (NYSE:BAC). Berkshire Hathaway owns over 1.03 billion shares of BofA with a cost basis of $14.17 a share. This works out to an unrealized gain of just over $24.5 billion, based on where BofA shares closed this past Friday, July 16.</p>\n<p>Buffett has always been a big fan of playing the economic numbers game, which is exactly what he's doing with Bank of America. Since the U.S. economy spends a disproportionate amount of time expanding, relative to contracting, bank stocks like BofA should benefit from stronger loan origination and higher net interest income. The Oracle of Omaha is fully aware that recessions are a natural part of the economic cycle, but he fully understands that the long term strongly favors optimists.</p>\n<p>More specific to the business, BofA stands to benefit from eventual interest rate hikes by the Federal Reserve. Bank of America is the most interest-sensitive of all the big banks, with the company noting in the June-ended quarter that a 100 basis point parallel shift in the interest rate yield curve would net it an extra $8 billion in net interest income over the next 12 months.</p>\n<p>With BofA pushing digitization initiatives and bolstering its dividend program, it's far likelier that Buffett ups his stake in the company than sells a single share.</p>\n<p><img src=\"https://static.tigerbbs.com/ed3e6a16841306014bf0cfc3b1697b23\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: American <a href=\"https://laohu8.com/S/EXPR\">Express</a>.</p>\n<h2>American Express: $24,488,160,264 in unrealized gains</h2>\n<p>Whereas the gains racked up in Apple and BofA have come within the past couple of years, the nearly $24.5 billion in unrealized gains in credit services behemoth <b>American Express</b> (NYSE:AXP) have been built up over the past 28 years. With a cost basis of right around $8.49 a share, Buffett's patience has paid off in a big way with AmEx.</p>\n<p>Similar to Bank of America, American Express is a cyclical company that benefits from the aforementioned numbers game. If the U.S. and global economy are expanding, consumers and businesses are more likely to spend more, thereby helping boost payment processing revenue and profits. Keep in mind, though, AmEx is a double dipper. In addition to processing payments, it's also a credit services provider. This means it can generate growing amounts of fee revenue and interest income during long-winded periods of expansion.</p>\n<p>Another facet to AmEx's success is the company's ability to bring in affluent clientele. The well-to-do are far less inclined to alter their spending habits when minor economic disruptions rear their heads. As a result, AmEx isn't as likely to be hurt by credit delinquencies as some of its lending peers.</p>\n<p>With Berkshire Hathaway an American Express shareholder since 1993, I don't foresee Buffett or his team selling shares anytime soon.</p>\n<p><img src=\"https://static.tigerbbs.com/299023e9f7694c143fc3162fbb154afa\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Coca-Cola.</p>\n<h3>Coca-Cola: $21,262,000,000 in unrealized gains</h3>\n<p>Speaking of tenured holdings, no stock has been a fixture in Buffett's portfolio for longer than beverage giant <b>Coca-Cola</b> (NYSE:KO). With a cost basis of a fraction under $3.25 a share, Buffett and his team have piled up almost $21.3 billion in unrealized gains by owning Coca-Cola since 1988.</p>\n<p>Like Apple, we're talking about a company with insanely strong branding and brand recognition. Coke products are sold in all but two countries worldwide (Cuba and North Korea), and it has more than 20 brands in its product portfolio generating at least $1 billion in annual sales. Coca-Cola enjoys the best of both worlds, with 20% of the developed market cold beverage share (i.e., highly predictable cash flow) and 10% of emerging market cold beverage share, which represents a higher-growth opportunity over the long run.</p>\n<p>Beyond geographic diversity, marketing is a big reason for Coca-Cola's success. The company has not been shy about turning to social media and well-known ambassadors to represent its brand, and it has clear holiday tie-ins that go back decades.</p>\n<p>Considering that Berkshire Hathaway is netting almost a 52% annual dividend yield based on its original cost basis for Coca-Cola, there's absolutely no incentive to sell this position.</p>\n<p><img src=\"https://static.tigerbbs.com/0405d7e87cf0321a7d9113d036c164a4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Moody's: $9,076,258,024 in unrealized gains</h3>\n<p>While Apple singlehandedly takes the crown for generating the highest unrealized return in nominal dollars for the Oracle of Omaha, credit ratings agency <b>Moody's</b> (NYSE:MCO) might well be Warren Buffett's greatest investment on a percentage basis of all time. Berkshire's cost basis is $10.05 a share following Moody's spinoff from Dun &amp; Bradstreet in 2000. Moody's closed this past week at almost $378 a share -- good enough for a 3,661% return and nearly $9.1 billion unrealized gain.</p>\n<p>One thing keeping Moody's busy is historically low lending rates. With the Federal Reserve standing pat for as long as possible on interest rates, businesses haven't been shy about issuing debt to hire, acquire, innovate, or even buy back stock, as in Apple's case. With so much corporate debt issued, Moody's has been active evaluating the debt landscape.</p>\n<p>Equally exciting has been the generally heightened levels of market volatility and economic uncertainty since the beginning of 2020. Though Moody's is best known for its credit ratings operations, its fastest-growing segment tends to be analytics. As long as deep levels of uncertainty exist, Moody's Analytics has double-digit annual growth potential.</p>\n<p>As with Coke, Buffett's patience has resulted in an insanely high yield on cost with Moody's. Despite a 0.7% nominal yield, Berkshire Hathaway is netting an almost 25% yield annually, based on its initial cost basis.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Has Gained Over $181 Billion on These 5 Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Has Gained Over $181 Billion on These 5 Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 11:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KO":"可口可乐","AXP":"美国运通","BRK.B":"伯克希尔B","MCO":"穆迪","BRK.A":"伯克希尔","BAC":"美国银行","AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153787206","content_text":"Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of Omaha has led his stock to an average annual return of 20%. Taking into account the 20% year-to-date gain for Berkshire's Class A shares (BRK.A), shareholders have seen Buffett generate aggregate returns of almost 3,400,000% in 56 years.\nAlthough Berkshire Hathaway has a relatively large portfolio filled with four dozen different securities, Buffett has never been a big fan of diversification. As a result, only a small number of holdings comprise the bulk of Berkshire Hathaway's $206.4 billion in unrealized gains, as of this past weekend.\nBased on the cost basis of Berkshire's major holdings (outlined in the company's 2020 annual shareholder letter), the following five stocks have netted Buffett $181.1 billion in combined unrealized gains (about 88% of all current unrealized profit), not including dividends paid.\n\nBerkshire Hathaway CEO Warren Buffett is all smiles with his company sitting on over $206 billion in unrealized gains. Image source: The Motley Fool.\nApple: $101,764,676,001 in unrealized gains\nEasily the best investment of Buffett's tenured career is Apple (NASDAQ:AAPL). Even after modestly paring down his company's stake in the tech kingpin, Berkshire Hathaway still owns 907,559,761 shares at a cost basis of $34.26 a share. With Apple closing last week at $146.39 a share, the Oracle of Omaha and his team are sitting on close to a $102 billion unrealized gain.\nInvestors certainly shouldn't look for this stake to be reduced any further anytime soon. That's because Buffett views Apple as Berkshire Hathaway's \"third business.\" It's a globally recognized brand with an exceptionally loyal following, as evidenced by the mammoth lines outside of its stores anytime a new product hits the shelves. And, as you're probably aware, the iPhone is the dominant smartphone by market share in the U.S.\nIn addition to Apple being a product innovation juggernaut, CEO Tim Cook is overseeing a steady transition toward services. By emphasizing various subscription-based platforms, Apple can reduce some of the revenue lumpiness associated with tech replacement cycles and likely boost its operating margins.\nA final reason Buffett isn't bailing on Apple is the company's generous shareholder return program. Though some of you might be scratching your head given that Apple's dividend yield is \"only\" 0.6%, the $0.88 base annual payout is closer to 2.6% of Berkshire Hathaway's cost basis. Tack on Apple's aggressive share repurchase program and you have a very shareholder-friendly company.\n\nImage source: Getty Images.\nBank of America: $24,530,235,143 in unrealized gains\nThere's no industry on the planet Buffett loves more than bank stocks -- and there's no bank stock Buffett favors more than Bank of America (NYSE:BAC). Berkshire Hathaway owns over 1.03 billion shares of BofA with a cost basis of $14.17 a share. This works out to an unrealized gain of just over $24.5 billion, based on where BofA shares closed this past Friday, July 16.\nBuffett has always been a big fan of playing the economic numbers game, which is exactly what he's doing with Bank of America. Since the U.S. economy spends a disproportionate amount of time expanding, relative to contracting, bank stocks like BofA should benefit from stronger loan origination and higher net interest income. The Oracle of Omaha is fully aware that recessions are a natural part of the economic cycle, but he fully understands that the long term strongly favors optimists.\nMore specific to the business, BofA stands to benefit from eventual interest rate hikes by the Federal Reserve. Bank of America is the most interest-sensitive of all the big banks, with the company noting in the June-ended quarter that a 100 basis point parallel shift in the interest rate yield curve would net it an extra $8 billion in net interest income over the next 12 months.\nWith BofA pushing digitization initiatives and bolstering its dividend program, it's far likelier that Buffett ups his stake in the company than sells a single share.\n\nImage source: American Express.\nAmerican Express: $24,488,160,264 in unrealized gains\nWhereas the gains racked up in Apple and BofA have come within the past couple of years, the nearly $24.5 billion in unrealized gains in credit services behemoth American Express (NYSE:AXP) have been built up over the past 28 years. With a cost basis of right around $8.49 a share, Buffett's patience has paid off in a big way with AmEx.\nSimilar to Bank of America, American Express is a cyclical company that benefits from the aforementioned numbers game. If the U.S. and global economy are expanding, consumers and businesses are more likely to spend more, thereby helping boost payment processing revenue and profits. Keep in mind, though, AmEx is a double dipper. In addition to processing payments, it's also a credit services provider. This means it can generate growing amounts of fee revenue and interest income during long-winded periods of expansion.\nAnother facet to AmEx's success is the company's ability to bring in affluent clientele. The well-to-do are far less inclined to alter their spending habits when minor economic disruptions rear their heads. As a result, AmEx isn't as likely to be hurt by credit delinquencies as some of its lending peers.\nWith Berkshire Hathaway an American Express shareholder since 1993, I don't foresee Buffett or his team selling shares anytime soon.\n\nImage source: Coca-Cola.\nCoca-Cola: $21,262,000,000 in unrealized gains\nSpeaking of tenured holdings, no stock has been a fixture in Buffett's portfolio for longer than beverage giant Coca-Cola (NYSE:KO). With a cost basis of a fraction under $3.25 a share, Buffett and his team have piled up almost $21.3 billion in unrealized gains by owning Coca-Cola since 1988.\nLike Apple, we're talking about a company with insanely strong branding and brand recognition. Coke products are sold in all but two countries worldwide (Cuba and North Korea), and it has more than 20 brands in its product portfolio generating at least $1 billion in annual sales. Coca-Cola enjoys the best of both worlds, with 20% of the developed market cold beverage share (i.e., highly predictable cash flow) and 10% of emerging market cold beverage share, which represents a higher-growth opportunity over the long run.\nBeyond geographic diversity, marketing is a big reason for Coca-Cola's success. The company has not been shy about turning to social media and well-known ambassadors to represent its brand, and it has clear holiday tie-ins that go back decades.\nConsidering that Berkshire Hathaway is netting almost a 52% annual dividend yield based on its original cost basis for Coca-Cola, there's absolutely no incentive to sell this position.\n\nImage source: Getty Images.\nMoody's: $9,076,258,024 in unrealized gains\nWhile Apple singlehandedly takes the crown for generating the highest unrealized return in nominal dollars for the Oracle of Omaha, credit ratings agency Moody's (NYSE:MCO) might well be Warren Buffett's greatest investment on a percentage basis of all time. Berkshire's cost basis is $10.05 a share following Moody's spinoff from Dun & Bradstreet in 2000. Moody's closed this past week at almost $378 a share -- good enough for a 3,661% return and nearly $9.1 billion unrealized gain.\nOne thing keeping Moody's busy is historically low lending rates. With the Federal Reserve standing pat for as long as possible on interest rates, businesses haven't been shy about issuing debt to hire, acquire, innovate, or even buy back stock, as in Apple's case. With so much corporate debt issued, Moody's has been active evaluating the debt landscape.\nEqually exciting has been the generally heightened levels of market volatility and economic uncertainty since the beginning of 2020. Though Moody's is best known for its credit ratings operations, its fastest-growing segment tends to be analytics. As long as deep levels of uncertainty exist, Moody's Analytics has double-digit annual growth potential.\nAs with Coke, Buffett's patience has resulted in an insanely high yield on cost with Moody's. Despite a 0.7% nominal yield, Berkshire Hathaway is netting an almost 25% yield annually, based on its initial cost basis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172265250,"gmtCreate":1626962993070,"gmtModify":1703481489946,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"More to come for rising stock ??","listText":"More to come for rising stock ??","text":"More to come for rising stock ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/172265250","repostId":"1100978830","repostType":4,"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172262859,"gmtCreate":1626962953671,"gmtModify":1703481488159,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"More to come ??","listText":"More to come ??","text":"More to come ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/172262859","repostId":"1100978830","repostType":4,"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571699784798633","authorId":"3571699784798633","name":"PumpItUp","avatar":"https://static.tigerbbs.com/be2a05fd6a34da9d3a9d1ff63df025cf","crmLevel":2,"crmLevelSwitch":0,"idStr":"3571699784798633","authorIdStr":"3571699784798633"},"content":"TO THE MOOOON","text":"TO THE MOOOON","html":"TO THE MOOOON"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157266154,"gmtCreate":1625584085378,"gmtModify":1703744444839,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Canabis stock ?","listText":"Canabis stock ?","text":"Canabis stock ?","images":[{"img":"https://static.tigerbbs.com/f828e6da081d426cc379438286eda1f6","width":"1080","height":"3429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157266154","isVote":1,"tweetType":1,"viewCount":36,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":157288318,"gmtCreate":1625583517434,"gmtModify":1703744429187,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Interesting news","listText":"Interesting news","text":"Interesting news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157288318","repostId":"2149365690","repostType":2,"isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125397047,"gmtCreate":1624648751289,"gmtModify":1703842774981,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Interesting ?","listText":"Interesting ?","text":"Interesting ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/125397047","repostId":"1134836867","repostType":4,"repost":{"id":"1134836867","pubTimestamp":1624634837,"share":"https://ttm.financial/m/news/1134836867?lang=&edition=fundamental","pubTime":"2021-06-25 23:27","market":"us","language":"en","title":"Kyle Bass Slams Fed, Sees Inflation Everywhere He Looks","url":"https://stock-news.laohu8.com/highlight/detail?id=1134836867","media":"zerohedge","summary":"With US stocks back at all-time highs as the market seemingly shrugged off the FOMC's reaction to th","content":"<p>With US stocks back at all-time highs as the market seemingly shrugged off the FOMC's reaction to the latest inflation numbers,Hayman Capital's Kyle Bass returned to CNBCfor an interview with the \"Closing Bell\" crew on Thursday, where he offered a dramatically different vision of the present economic scenario vis-a-vis inflation.</p>\n<p>Inan interview where heexpounded upon his claim that the US is already grappling with real inflation rates above 10%, the billionaire investor proclaimed that \"in every single aspect of life, I see inflation.\"</p>\n<p><img src=\"https://static.tigerbbs.com/d1d2089581ea201564daaba8b5aac961\" tg-width=\"521\" tg-height=\"310\"></p>\n<p>Why? Because during the past year and a half, the Fed has introduced more broad money into the American economy in the shortest time than we have seen at any point in American history.</p>\n<blockquote>\n \"I think look we're going to see a short-term turn-down in inflation because the initial inflationary burst was enormous...this transitory comment may play out to be true for a short period of time but I hink Sarah when you look at the the money supply the broad money in the US system from 1980 to 2010 it it vacillated between 50% and 60% of GDP and post the global financial crisis it moved up from roughly 60% to 68% 69% of GDP now that we're approaching 90 so in the one year period one and a half year period since COVID started we have introduced 34% more broad money in our system in the shortest time period in the history United States so we're going to see prices stay high and move higher over time if the fed continues to expand its balance sheet,\" Bass said.\n</blockquote>\n<p>Even as the financial press prattles on about the significance of the Fed finally starting to consider tapering its asset purchases, Bass believes that the central bank won't be able to shrink its balance sheet so easily.</p>\n<blockquote>\n \"We're going to see prices stay high and move higher over time if the Fed continues to expand its balance sheet which I think it will,\" Bass said.\n</blockquote>\n<p>So, what can investors do to fight this \"inflation monster\", as Bass colorfully described it. Well, he suggested they focus on hard assets like commodities and real estate,which BlackRock is already buying up in droves.</p>\n<p>Equities should \"do fine\", Bass said, citing data purporting to show that equity prices keep up with between 95% and 88% of inflation over the long term (though that certainly doesn't seem to fit the last decade).</p>\n<p>As for his assessment of inflation and its dramatic difference with the Fed's view, Bass quipped: \"Your bank account is the final determinant whether there is inflation or not,\" he concluded, highlighting the higher prices consumers have seen for things like food and cars.\"</p>\n<blockquote>\n \"If you're in the market place you want to own commodities if you’re in the real world you want to own productive real estate you even want to buy rural land in front of major demographic moves in the US...I’d rather own hard assets than equities today because I think we’re only seeing just the beginning of population moves in the US.\"\n</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kyle Bass Slams Fed, Sees Inflation Everywhere He Looks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKyle Bass Slams Fed, Sees Inflation Everywhere He Looks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/kyle-bass-warns-every-aspect-my-life-i-see-inflation?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With US stocks back at all-time highs as the market seemingly shrugged off the FOMC's reaction to the latest inflation numbers,Hayman Capital's Kyle Bass returned to CNBCfor an interview with the \"...</p>\n\n<a href=\"https://www.zerohedge.com/markets/kyle-bass-warns-every-aspect-my-life-i-see-inflation?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"source_url":"https://www.zerohedge.com/markets/kyle-bass-warns-every-aspect-my-life-i-see-inflation?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134836867","content_text":"With US stocks back at all-time highs as the market seemingly shrugged off the FOMC's reaction to the latest inflation numbers,Hayman Capital's Kyle Bass returned to CNBCfor an interview with the \"Closing Bell\" crew on Thursday, where he offered a dramatically different vision of the present economic scenario vis-a-vis inflation.\nInan interview where heexpounded upon his claim that the US is already grappling with real inflation rates above 10%, the billionaire investor proclaimed that \"in every single aspect of life, I see inflation.\"\n\nWhy? Because during the past year and a half, the Fed has introduced more broad money into the American economy in the shortest time than we have seen at any point in American history.\n\n \"I think look we're going to see a short-term turn-down in inflation because the initial inflationary burst was enormous...this transitory comment may play out to be true for a short period of time but I hink Sarah when you look at the the money supply the broad money in the US system from 1980 to 2010 it it vacillated between 50% and 60% of GDP and post the global financial crisis it moved up from roughly 60% to 68% 69% of GDP now that we're approaching 90 so in the one year period one and a half year period since COVID started we have introduced 34% more broad money in our system in the shortest time period in the history United States so we're going to see prices stay high and move higher over time if the fed continues to expand its balance sheet,\" Bass said.\n\nEven as the financial press prattles on about the significance of the Fed finally starting to consider tapering its asset purchases, Bass believes that the central bank won't be able to shrink its balance sheet so easily.\n\n \"We're going to see prices stay high and move higher over time if the Fed continues to expand its balance sheet which I think it will,\" Bass said.\n\nSo, what can investors do to fight this \"inflation monster\", as Bass colorfully described it. Well, he suggested they focus on hard assets like commodities and real estate,which BlackRock is already buying up in droves.\nEquities should \"do fine\", Bass said, citing data purporting to show that equity prices keep up with between 95% and 88% of inflation over the long term (though that certainly doesn't seem to fit the last decade).\nAs for his assessment of inflation and its dramatic difference with the Fed's view, Bass quipped: \"Your bank account is the final determinant whether there is inflation or not,\" he concluded, highlighting the higher prices consumers have seen for things like food and cars.\"\n\n \"If you're in the market place you want to own commodities if you’re in the real world you want to own productive real estate you even want to buy rural land in front of major demographic moves in the US...I’d rather own hard assets than equities today because I think we’re only seeing just the beginning of population moves in the US.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125394268,"gmtCreate":1624648689954,"gmtModify":1703842774161,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125394268","repostId":"1119853713","repostType":4,"isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125920635,"gmtCreate":1624642080527,"gmtModify":1703842689295,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"RPA stock","listText":"RPA stock","text":"RPA stock","images":[{"img":"https://static.tigerbbs.com/7fae4adbc9a0d9a4db0818c99a19a836","width":"1080","height":"3429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125920635","isVote":1,"tweetType":1,"viewCount":91,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":172262859,"gmtCreate":1626962953671,"gmtModify":1703481488159,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"More to come ??","listText":"More to come ??","text":"More to come ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/172262859","repostId":"1100978830","repostType":4,"repost":{"id":"1100978830","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626961977,"share":"https://ttm.financial/m/news/1100978830?lang=&edition=fundamental","pubTime":"2021-07-22 21:52","market":"us","language":"en","title":"Microsoft rose over 1%, reaching record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1100978830","media":"Tiger Newspress","summary":"(July 22) Microsoft rose over 1%, reaching record high.","content":"<p>(July 22)&nbsp;<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> rose over 1%, reaching record high.</p>\n<p><img src=\"https://static.tigerbbs.com/d3e01b3a96334ab3ef727b20a2606ffb\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft rose over 1%, reaching record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft rose over 1%, reaching record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-22 21:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July 22)&nbsp;<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> rose over 1%, reaching record high.</p>\n<p><img src=\"https://static.tigerbbs.com/d3e01b3a96334ab3ef727b20a2606ffb\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"03086":"华夏纳指","09086":"华夏纳指-U","MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100978830","content_text":"(July 22) Microsoft rose over 1%, reaching record high.","news_type":1},"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571699784798633","authorId":"3571699784798633","name":"PumpItUp","avatar":"https://static.tigerbbs.com/be2a05fd6a34da9d3a9d1ff63df025cf","crmLevel":2,"crmLevelSwitch":0,"idStr":"3571699784798633","authorIdStr":"3571699784798633"},"content":"TO THE MOOOON","text":"TO THE MOOOON","html":"TO THE MOOOON"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172265250,"gmtCreate":1626962993070,"gmtModify":1703481489946,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"More to come for rising stock ??","listText":"More to come for rising stock ??","text":"More to come for rising stock ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/172265250","repostId":"1100978830","repostType":4,"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172220563,"gmtCreate":1626963122352,"gmtModify":1703481494717,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Pls cmon coke, boa? ?","listText":"Pls cmon coke, boa? ?","text":"Pls cmon coke, boa? ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172220563","repostId":"2153787206","repostType":4,"repost":{"id":"2153787206","pubTimestamp":1627011840,"share":"https://ttm.financial/m/news/2153787206?lang=&edition=fundamental","pubTime":"2021-07-23 11:44","market":"us","language":"en","title":"Warren Buffett Has Gained Over $181 Billion on These 5 Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2153787206","media":"Motley Fool","summary":"These five holdings account for 88% of Berkshire Hathaway's unrealized gains.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of Omaha has led his stock to an average annual return of 20%. Taking into account the 20% year-to-date gain for Berkshire's Class A shares (BRK.A), shareholders have seen Buffett generate aggregate returns of almost 3,400,000% in 56 years.</p>\n<p>Although Berkshire Hathaway has a relatively large portfolio filled with four dozen different securities, Buffett has never been a big fan of diversification. As a result, only a small number of holdings comprise the bulk of Berkshire Hathaway's $206.4 billion in unrealized gains, as of this past weekend.</p>\n<p>Based on the cost basis of Berkshire's major holdings (outlined in the company's 2020 annual shareholder letter), the following five stocks have netted Buffett $181.1 billion in combined unrealized gains (about 88% of all current unrealized profit), not including dividends paid.</p>\n<p><img src=\"https://static.tigerbbs.com/d28b3a8823057ce2bc2495cefe7ee3ff\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Berkshire Hathaway CEO Warren Buffett is all smiles with his company sitting on over $206 billion in unrealized gains. Image source: The Motley Fool.</p>\n<h3>Apple: $101,764,676,001 in unrealized gains</h3>\n<p>Easily the best investment of Buffett's tenured career is <b>Apple</b> (NASDAQ:AAPL). Even after modestly paring down his company's stake in the tech kingpin, Berkshire Hathaway still owns 907,559,761 shares at a cost basis of $34.26 a share. With Apple closing last week at $146.39 a share, the Oracle of Omaha and his team are sitting on close to a $102 billion unrealized gain.</p>\n<p>Investors certainly shouldn't look for this stake to be reduced any further anytime soon. That's because Buffett views Apple as Berkshire Hathaway's \"third business.\" It's a globally recognized brand with an exceptionally loyal following, as evidenced by the mammoth lines outside of its stores anytime a new product hits the shelves. And, as you're probably aware, the iPhone is the dominant smartphone by market share in the U.S.</p>\n<p>In addition to Apple being a product innovation juggernaut, CEO Tim Cook is overseeing a steady transition toward services. By emphasizing various subscription-based platforms, Apple can reduce some of the revenue lumpiness associated with tech replacement cycles and likely boost its operating margins.</p>\n<p>A final reason Buffett isn't bailing on Apple is the company's generous shareholder return program. Though some of you might be scratching your head given that Apple's dividend yield is \"only\" 0.6%, the $0.88 base annual payout is closer to 2.6% of Berkshire Hathaway's cost basis. Tack on Apple's aggressive share repurchase program and you have a very shareholder-friendly company.</p>\n<p><img src=\"https://static.tigerbbs.com/44a30c4dfd6886a29e22d3c6558c3e56\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Bank of America: $24,530,235,143 in unrealized gains</h3>\n<p>There's no industry on the planet Buffett loves more than bank stocks -- and there's no bank stock Buffett favors more than <b>Bank of America</b> (NYSE:BAC). Berkshire Hathaway owns over 1.03 billion shares of BofA with a cost basis of $14.17 a share. This works out to an unrealized gain of just over $24.5 billion, based on where BofA shares closed this past Friday, July 16.</p>\n<p>Buffett has always been a big fan of playing the economic numbers game, which is exactly what he's doing with Bank of America. Since the U.S. economy spends a disproportionate amount of time expanding, relative to contracting, bank stocks like BofA should benefit from stronger loan origination and higher net interest income. The Oracle of Omaha is fully aware that recessions are a natural part of the economic cycle, but he fully understands that the long term strongly favors optimists.</p>\n<p>More specific to the business, BofA stands to benefit from eventual interest rate hikes by the Federal Reserve. Bank of America is the most interest-sensitive of all the big banks, with the company noting in the June-ended quarter that a 100 basis point parallel shift in the interest rate yield curve would net it an extra $8 billion in net interest income over the next 12 months.</p>\n<p>With BofA pushing digitization initiatives and bolstering its dividend program, it's far likelier that Buffett ups his stake in the company than sells a single share.</p>\n<p><img src=\"https://static.tigerbbs.com/ed3e6a16841306014bf0cfc3b1697b23\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: American <a href=\"https://laohu8.com/S/EXPR\">Express</a>.</p>\n<h2>American Express: $24,488,160,264 in unrealized gains</h2>\n<p>Whereas the gains racked up in Apple and BofA have come within the past couple of years, the nearly $24.5 billion in unrealized gains in credit services behemoth <b>American Express</b> (NYSE:AXP) have been built up over the past 28 years. With a cost basis of right around $8.49 a share, Buffett's patience has paid off in a big way with AmEx.</p>\n<p>Similar to Bank of America, American Express is a cyclical company that benefits from the aforementioned numbers game. If the U.S. and global economy are expanding, consumers and businesses are more likely to spend more, thereby helping boost payment processing revenue and profits. Keep in mind, though, AmEx is a double dipper. In addition to processing payments, it's also a credit services provider. This means it can generate growing amounts of fee revenue and interest income during long-winded periods of expansion.</p>\n<p>Another facet to AmEx's success is the company's ability to bring in affluent clientele. The well-to-do are far less inclined to alter their spending habits when minor economic disruptions rear their heads. As a result, AmEx isn't as likely to be hurt by credit delinquencies as some of its lending peers.</p>\n<p>With Berkshire Hathaway an American Express shareholder since 1993, I don't foresee Buffett or his team selling shares anytime soon.</p>\n<p><img src=\"https://static.tigerbbs.com/299023e9f7694c143fc3162fbb154afa\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Coca-Cola.</p>\n<h3>Coca-Cola: $21,262,000,000 in unrealized gains</h3>\n<p>Speaking of tenured holdings, no stock has been a fixture in Buffett's portfolio for longer than beverage giant <b>Coca-Cola</b> (NYSE:KO). With a cost basis of a fraction under $3.25 a share, Buffett and his team have piled up almost $21.3 billion in unrealized gains by owning Coca-Cola since 1988.</p>\n<p>Like Apple, we're talking about a company with insanely strong branding and brand recognition. Coke products are sold in all but two countries worldwide (Cuba and North Korea), and it has more than 20 brands in its product portfolio generating at least $1 billion in annual sales. Coca-Cola enjoys the best of both worlds, with 20% of the developed market cold beverage share (i.e., highly predictable cash flow) and 10% of emerging market cold beverage share, which represents a higher-growth opportunity over the long run.</p>\n<p>Beyond geographic diversity, marketing is a big reason for Coca-Cola's success. The company has not been shy about turning to social media and well-known ambassadors to represent its brand, and it has clear holiday tie-ins that go back decades.</p>\n<p>Considering that Berkshire Hathaway is netting almost a 52% annual dividend yield based on its original cost basis for Coca-Cola, there's absolutely no incentive to sell this position.</p>\n<p><img src=\"https://static.tigerbbs.com/0405d7e87cf0321a7d9113d036c164a4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Moody's: $9,076,258,024 in unrealized gains</h3>\n<p>While Apple singlehandedly takes the crown for generating the highest unrealized return in nominal dollars for the Oracle of Omaha, credit ratings agency <b>Moody's</b> (NYSE:MCO) might well be Warren Buffett's greatest investment on a percentage basis of all time. Berkshire's cost basis is $10.05 a share following Moody's spinoff from Dun &amp; Bradstreet in 2000. Moody's closed this past week at almost $378 a share -- good enough for a 3,661% return and nearly $9.1 billion unrealized gain.</p>\n<p>One thing keeping Moody's busy is historically low lending rates. With the Federal Reserve standing pat for as long as possible on interest rates, businesses haven't been shy about issuing debt to hire, acquire, innovate, or even buy back stock, as in Apple's case. With so much corporate debt issued, Moody's has been active evaluating the debt landscape.</p>\n<p>Equally exciting has been the generally heightened levels of market volatility and economic uncertainty since the beginning of 2020. Though Moody's is best known for its credit ratings operations, its fastest-growing segment tends to be analytics. As long as deep levels of uncertainty exist, Moody's Analytics has double-digit annual growth potential.</p>\n<p>As with Coke, Buffett's patience has resulted in an insanely high yield on cost with Moody's. Despite a 0.7% nominal yield, Berkshire Hathaway is netting an almost 25% yield annually, based on its initial cost basis.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Has Gained Over $181 Billion on These 5 Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Has Gained Over $181 Billion on These 5 Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 11:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KO":"可口可乐","AXP":"美国运通","BRK.B":"伯克希尔B","MCO":"穆迪","BRK.A":"伯克希尔","BAC":"美国银行","AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153787206","content_text":"Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of Omaha has led his stock to an average annual return of 20%. Taking into account the 20% year-to-date gain for Berkshire's Class A shares (BRK.A), shareholders have seen Buffett generate aggregate returns of almost 3,400,000% in 56 years.\nAlthough Berkshire Hathaway has a relatively large portfolio filled with four dozen different securities, Buffett has never been a big fan of diversification. As a result, only a small number of holdings comprise the bulk of Berkshire Hathaway's $206.4 billion in unrealized gains, as of this past weekend.\nBased on the cost basis of Berkshire's major holdings (outlined in the company's 2020 annual shareholder letter), the following five stocks have netted Buffett $181.1 billion in combined unrealized gains (about 88% of all current unrealized profit), not including dividends paid.\n\nBerkshire Hathaway CEO Warren Buffett is all smiles with his company sitting on over $206 billion in unrealized gains. Image source: The Motley Fool.\nApple: $101,764,676,001 in unrealized gains\nEasily the best investment of Buffett's tenured career is Apple (NASDAQ:AAPL). Even after modestly paring down his company's stake in the tech kingpin, Berkshire Hathaway still owns 907,559,761 shares at a cost basis of $34.26 a share. With Apple closing last week at $146.39 a share, the Oracle of Omaha and his team are sitting on close to a $102 billion unrealized gain.\nInvestors certainly shouldn't look for this stake to be reduced any further anytime soon. That's because Buffett views Apple as Berkshire Hathaway's \"third business.\" It's a globally recognized brand with an exceptionally loyal following, as evidenced by the mammoth lines outside of its stores anytime a new product hits the shelves. And, as you're probably aware, the iPhone is the dominant smartphone by market share in the U.S.\nIn addition to Apple being a product innovation juggernaut, CEO Tim Cook is overseeing a steady transition toward services. By emphasizing various subscription-based platforms, Apple can reduce some of the revenue lumpiness associated with tech replacement cycles and likely boost its operating margins.\nA final reason Buffett isn't bailing on Apple is the company's generous shareholder return program. Though some of you might be scratching your head given that Apple's dividend yield is \"only\" 0.6%, the $0.88 base annual payout is closer to 2.6% of Berkshire Hathaway's cost basis. Tack on Apple's aggressive share repurchase program and you have a very shareholder-friendly company.\n\nImage source: Getty Images.\nBank of America: $24,530,235,143 in unrealized gains\nThere's no industry on the planet Buffett loves more than bank stocks -- and there's no bank stock Buffett favors more than Bank of America (NYSE:BAC). Berkshire Hathaway owns over 1.03 billion shares of BofA with a cost basis of $14.17 a share. This works out to an unrealized gain of just over $24.5 billion, based on where BofA shares closed this past Friday, July 16.\nBuffett has always been a big fan of playing the economic numbers game, which is exactly what he's doing with Bank of America. Since the U.S. economy spends a disproportionate amount of time expanding, relative to contracting, bank stocks like BofA should benefit from stronger loan origination and higher net interest income. The Oracle of Omaha is fully aware that recessions are a natural part of the economic cycle, but he fully understands that the long term strongly favors optimists.\nMore specific to the business, BofA stands to benefit from eventual interest rate hikes by the Federal Reserve. Bank of America is the most interest-sensitive of all the big banks, with the company noting in the June-ended quarter that a 100 basis point parallel shift in the interest rate yield curve would net it an extra $8 billion in net interest income over the next 12 months.\nWith BofA pushing digitization initiatives and bolstering its dividend program, it's far likelier that Buffett ups his stake in the company than sells a single share.\n\nImage source: American Express.\nAmerican Express: $24,488,160,264 in unrealized gains\nWhereas the gains racked up in Apple and BofA have come within the past couple of years, the nearly $24.5 billion in unrealized gains in credit services behemoth American Express (NYSE:AXP) have been built up over the past 28 years. With a cost basis of right around $8.49 a share, Buffett's patience has paid off in a big way with AmEx.\nSimilar to Bank of America, American Express is a cyclical company that benefits from the aforementioned numbers game. If the U.S. and global economy are expanding, consumers and businesses are more likely to spend more, thereby helping boost payment processing revenue and profits. Keep in mind, though, AmEx is a double dipper. In addition to processing payments, it's also a credit services provider. This means it can generate growing amounts of fee revenue and interest income during long-winded periods of expansion.\nAnother facet to AmEx's success is the company's ability to bring in affluent clientele. The well-to-do are far less inclined to alter their spending habits when minor economic disruptions rear their heads. As a result, AmEx isn't as likely to be hurt by credit delinquencies as some of its lending peers.\nWith Berkshire Hathaway an American Express shareholder since 1993, I don't foresee Buffett or his team selling shares anytime soon.\n\nImage source: Coca-Cola.\nCoca-Cola: $21,262,000,000 in unrealized gains\nSpeaking of tenured holdings, no stock has been a fixture in Buffett's portfolio for longer than beverage giant Coca-Cola (NYSE:KO). With a cost basis of a fraction under $3.25 a share, Buffett and his team have piled up almost $21.3 billion in unrealized gains by owning Coca-Cola since 1988.\nLike Apple, we're talking about a company with insanely strong branding and brand recognition. Coke products are sold in all but two countries worldwide (Cuba and North Korea), and it has more than 20 brands in its product portfolio generating at least $1 billion in annual sales. Coca-Cola enjoys the best of both worlds, with 20% of the developed market cold beverage share (i.e., highly predictable cash flow) and 10% of emerging market cold beverage share, which represents a higher-growth opportunity over the long run.\nBeyond geographic diversity, marketing is a big reason for Coca-Cola's success. The company has not been shy about turning to social media and well-known ambassadors to represent its brand, and it has clear holiday tie-ins that go back decades.\nConsidering that Berkshire Hathaway is netting almost a 52% annual dividend yield based on its original cost basis for Coca-Cola, there's absolutely no incentive to sell this position.\n\nImage source: Getty Images.\nMoody's: $9,076,258,024 in unrealized gains\nWhile Apple singlehandedly takes the crown for generating the highest unrealized return in nominal dollars for the Oracle of Omaha, credit ratings agency Moody's (NYSE:MCO) might well be Warren Buffett's greatest investment on a percentage basis of all time. Berkshire's cost basis is $10.05 a share following Moody's spinoff from Dun & Bradstreet in 2000. Moody's closed this past week at almost $378 a share -- good enough for a 3,661% return and nearly $9.1 billion unrealized gain.\nOne thing keeping Moody's busy is historically low lending rates. With the Federal Reserve standing pat for as long as possible on interest rates, businesses haven't been shy about issuing debt to hire, acquire, innovate, or even buy back stock, as in Apple's case. With so much corporate debt issued, Moody's has been active evaluating the debt landscape.\nEqually exciting has been the generally heightened levels of market volatility and economic uncertainty since the beginning of 2020. Though Moody's is best known for its credit ratings operations, its fastest-growing segment tends to be analytics. As long as deep levels of uncertainty exist, Moody's Analytics has double-digit annual growth potential.\nAs with Coke, Buffett's patience has resulted in an insanely high yield on cost with Moody's. Despite a 0.7% nominal yield, Berkshire Hathaway is netting an almost 25% yield annually, based on its initial cost basis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125397047,"gmtCreate":1624648751289,"gmtModify":1703842774981,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Interesting ?","listText":"Interesting ?","text":"Interesting ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/125397047","repostId":"1134836867","repostType":4,"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172221780,"gmtCreate":1626963213840,"gmtModify":1703481498758,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Still in uncertainty for sure ?","listText":"Still in uncertainty for sure ?","text":"Still in uncertainty for sure ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172221780","repostId":"2153673800","repostType":4,"repost":{"id":"2153673800","pubTimestamp":1626958140,"share":"https://ttm.financial/m/news/2153673800?lang=&edition=fundamental","pubTime":"2021-07-22 20:49","market":"us","language":"en","title":"What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2153673800","media":"Motley Fool","summary":"It shouldn't impact the healthcare giant very much.","content":"<p>Three months ago, the Food and Drug Administration placed a warning on the label for <b>Johnson &amp; Johnson</b>'s (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the regulator added another. In this <i>Motley Fool Live</i> video <b>recorded on July 14, 2021</b>, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning.</p>\n<p><b>Keith Speights:</b> Let's move on to another company that's in the news with COVID-19. The FDA has added a new warning to Johnson &amp; Johnson's COVID-19 vaccine, and this is related to a very rare neurological disorder. Brian, what's the potential issue here, and does this impact in any way Johnson &amp; Johnson's ability to market its vaccine?</p>\n<p><b>Brian Orelli:</b> The syndrome is called Guillain-Barre syndrome. It's characterized by numbness at the extremities. Most people recover, but it can lead to full-body paralysis. There has been about 100 cases in the 12 million people who have been vaccinated, and about half of those are coming in men 50 or older, so that seems to be the population that might be most susceptible.</p>\n<p>But if I did the math correctly, I think it's 0.0008% chance of getting this syndrome, so I don't think it's really a major issue. I think the warning by the FDA is probably more for doctors to be able to identify, know that it's happening in a very small number of people, and then they can treat it accordingly.</p>\n<p>I think that's probably the main take-home point here is that it's not a major issue, and I don't that it's going to affect sales of Johnson &amp; Johnson's vaccine in any sort of material way.</p>\n<p><b>Speights:</b> I would totally agree with you there, and it's not going to impact Johnson &amp; Johnson from an investing standpoint probably at all. The vaccine is still only a really small percentage of this company's total sales. Johnson &amp; Johnson is a healthcare giant, the biggest healthcare company in the world.</p>\n<p>My concern on this is doesn't have anything to do with Johnson &amp; Johnson actually. My only concern about this is it's just <a href=\"https://laohu8.com/S/AONE.U\">one</a> other thing for the remaining segment of Americans who are reluctant to take a vaccine, it's just one more thing to make them a little worried.</p>\n<p>Even though like you said, this is an extremely rare occurrence, it's one more thing for people who didn't want to take a vaccine in the first place to say, \"Ah yeah, they found something else with one of these vaccines.\"</p>\n<p><b>Orelli:</b> But your risk of dying from COVID is a lot worse than your risk of getting this disease that may just clear up on its own. I think that that's the message that the government has to get through to people that are on the fence and are not wanting to get the vaccine. But I think it's a difficult proposition to make.</p>\n<p><b>Speights:</b> Exactly. Of course, if anyone has ever watched a TV commercial promoting a prescription drug of any kind, you are going to note the announcer is going to -- very hastily, I might add -- read off a long list of potential side effects.</p>\n<p>I don't know that there's a drug or vaccine out there that doesn't have some type of potential side effect. But most of them are rare, and in this case, extremely rare. This isn't a big deal, in general. But again, my concern is there are folks out there who are looking for reasons not to take a vaccine.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-22 20:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Three months ago, the Food and Drug Administration placed a warning on the label for Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153673800","content_text":"Three months ago, the Food and Drug Administration placed a warning on the label for Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the regulator added another. In this Motley Fool Live video recorded on July 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning.\nKeith Speights: Let's move on to another company that's in the news with COVID-19. The FDA has added a new warning to Johnson & Johnson's COVID-19 vaccine, and this is related to a very rare neurological disorder. Brian, what's the potential issue here, and does this impact in any way Johnson & Johnson's ability to market its vaccine?\nBrian Orelli: The syndrome is called Guillain-Barre syndrome. It's characterized by numbness at the extremities. Most people recover, but it can lead to full-body paralysis. There has been about 100 cases in the 12 million people who have been vaccinated, and about half of those are coming in men 50 or older, so that seems to be the population that might be most susceptible.\nBut if I did the math correctly, I think it's 0.0008% chance of getting this syndrome, so I don't think it's really a major issue. I think the warning by the FDA is probably more for doctors to be able to identify, know that it's happening in a very small number of people, and then they can treat it accordingly.\nI think that's probably the main take-home point here is that it's not a major issue, and I don't that it's going to affect sales of Johnson & Johnson's vaccine in any sort of material way.\nSpeights: I would totally agree with you there, and it's not going to impact Johnson & Johnson from an investing standpoint probably at all. The vaccine is still only a really small percentage of this company's total sales. Johnson & Johnson is a healthcare giant, the biggest healthcare company in the world.\nMy concern on this is doesn't have anything to do with Johnson & Johnson actually. My only concern about this is it's just one other thing for the remaining segment of Americans who are reluctant to take a vaccine, it's just one more thing to make them a little worried.\nEven though like you said, this is an extremely rare occurrence, it's one more thing for people who didn't want to take a vaccine in the first place to say, \"Ah yeah, they found something else with one of these vaccines.\"\nOrelli: But your risk of dying from COVID is a lot worse than your risk of getting this disease that may just clear up on its own. I think that that's the message that the government has to get through to people that are on the fence and are not wanting to get the vaccine. But I think it's a difficult proposition to make.\nSpeights: Exactly. Of course, if anyone has ever watched a TV commercial promoting a prescription drug of any kind, you are going to note the announcer is going to -- very hastily, I might add -- read off a long list of potential side effects.\nI don't know that there's a drug or vaccine out there that doesn't have some type of potential side effect. But most of them are rare, and in this case, extremely rare. This isn't a big deal, in general. But again, my concern is there are folks out there who are looking for reasons not to take a vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157266154,"gmtCreate":1625584085378,"gmtModify":1703744444839,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Canabis stock ?","listText":"Canabis stock ?","text":"Canabis stock ?","images":[{"img":"https://static.tigerbbs.com/f828e6da081d426cc379438286eda1f6","width":"1080","height":"3429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157266154","isVote":1,"tweetType":1,"viewCount":36,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":157288318,"gmtCreate":1625583517434,"gmtModify":1703744429187,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Interesting news","listText":"Interesting news","text":"Interesting news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157288318","repostId":"2149365690","repostType":2,"repost":{"id":"2149365690","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1625582940,"share":"https://ttm.financial/m/news/2149365690?lang=&edition=fundamental","pubTime":"2021-07-06 22:49","market":"us","language":"en","title":"Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly","url":"https://stock-news.laohu8.com/highlight/detail?id=2149365690","media":"Dow Jones","summary":"MW Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread ","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly\n</p>\n<p>\n  Ciara Linnane \n</p>\n<p>\n  The global tally of confirmed cases of COVID-19 climbed above 184 million on Tuesday, as the highly transmissible delta variant continued to race across the world and the Israeli health ministry said it believes delta has weakened the overall effectiveness of its vaccine program. \n</p>\n<p>\n  Israel was an early success in the rush to vaccinate its residents but has fully vaccinated just 57% so far, according to Johns Hopkins University,  and has primarily used the vaccine developed by Pfizer and German partner BioNTech. That vaccine uses mRNA technology that is also used in the Moderna vaccine, both of which are authorized in the U.S. \n</p>\n<p>\n  The Israeli health ministry said it now believes the vaccine is just 64% effective at preventing symptomatic infections, which compares with the efficacy rate of about 95% in clinical trials back in 2020, it said in a statement posted on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>. The vaccine remains roughly 93% effective at preventing hospitalizations and death, the ministry said. Experts have repeatedly warned of the need to vaccinate at least 70% of the world's population to prevent new variants emerging that may prove resistant to the existing vaccines. \n</p>\n<p>\n  The news comes as Indonesia and Russia record daily death tolls, with Russian authorities reporting 737 more fatalities and a steep rise in new infections. Indonesia is sourcing oxygen from Singapore and calling on other countries to help as it counted a record 728 deaths in a single day, as AFP reported . \n</p>\n<p>\n  The prime minister of Luxembourg, Xavier Bettel, is in hospital suffering COVID symptoms, after testing positive and showing low oxygen levels in his blood, the Guardian reported. \"The prime minister's current medical condition is considered serious, but stable,\" the government said in a statement. \n</p>\n<p>\n</p>\n<p>\n  President Joe Biden is expected to speak later Tuesday on his administration's fight against the COVID-19 pandemic,  with the remarks coming after his administration fell short of his goal of having 70% of U.S. adults at least partially vaccinated by the Fourth of July. \n</p>\n<p>\n  Biden is due to speak at 2:45 p.m. Eastern in Washington about \"the COVID-19 response and the vaccination program,\" the White House said in a statement. \n</p>\n<p>\n  The percentage of U.S. adults who have received at least <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine dose stands at 67.1%, according to a Centers for Disease Control and Prevention tracker  vaccine has not been authorized for use in the U.S. \n</p>\n<p>\n  On Sunday, the president mixed the country's Independence Day party with a celebration of freedom from the worst of the pandemic, as he described getting vaccinated as \"the most patriotic thing you can do .\" \n</p>\n<p>\n  Meanwhile, pandemic restrictions on travel between the U.S. and neighboring Canada started to loosen on Monday for some Canadians, and Prime Minister Justin Trudeau said plans to totally reopen the border would be announced over the next few weeks, the Associated Press reported.   \n</p>\n<p>\n  Canadian citizens and permanent residents who have had a full dose of a coronavirus vaccine approved for use in Canada can skip a 14-day quarantine that has been a requirement since March 2020. Eligible air travelers also no longer have to spend their first three days in the country at a government-approved hotel. \n</p>\n<p>\n  Restrictions barring all non-essential trips between Canada and the United States, including tourism, will remain in place until at least July 21. \n</p>\n<p>\n  See also: Rising COVID-19 cases in California highlight risks of delta variant, as WHO head warns world in dangerous period of pandemic  \n</p>\n<p>\n  Latest tallies \n</p>\n<p>\n  The global tally for the coronavirus-borne illness headed above 184 million on Tuesday, according to data aggregated by Johns Hopkins University , while deaths climbed above 3.95 million. \n</p>\n<p>\n  The U.S. continues to lead the world in total cases at 33.7 million, and by deaths that total 605,567. \n</p>\n<p>\n  Don't miss: Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away  \n</p>\n<p>\n  India is second in total cases at 30.6 million and third by fatalities at 403,281. \n</p>\n<p>\n  Brazil has the third-highest caseload at 18.8 million, according to JHU data, and is second in deaths at 525,112. \n</p>\n<p>\n  Mexico has fourth-highest death toll at 233,689 and 2.5 million cases. \n</p>\n<p>\n  In Europe, Russia continues to pull ahead of the U.K. by deaths. Russia has 137,005 fatalities, while the U.K. has 128,495, making Russia the country with the fifth-highest death toll in the world and highest in Europe. \n</p>\n<p>\n  China, where the virus was first discovered late in 2019,  has had 103891 confirmed cases and 4,848 deaths, according to its official numbers, which are widely held to be massively underreported. \n</p>\n<p>\n  -Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  July 06, 2021 10:49 ET (14:49 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsrael says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-06 22:49</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly\n</p>\n<p>\n  Ciara Linnane \n</p>\n<p>\n  The global tally of confirmed cases of COVID-19 climbed above 184 million on Tuesday, as the highly transmissible delta variant continued to race across the world and the Israeli health ministry said it believes delta has weakened the overall effectiveness of its vaccine program. \n</p>\n<p>\n  Israel was an early success in the rush to vaccinate its residents but has fully vaccinated just 57% so far, according to Johns Hopkins University,  and has primarily used the vaccine developed by Pfizer and German partner BioNTech. That vaccine uses mRNA technology that is also used in the Moderna vaccine, both of which are authorized in the U.S. \n</p>\n<p>\n  The Israeli health ministry said it now believes the vaccine is just 64% effective at preventing symptomatic infections, which compares with the efficacy rate of about 95% in clinical trials back in 2020, it said in a statement posted on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>. The vaccine remains roughly 93% effective at preventing hospitalizations and death, the ministry said. Experts have repeatedly warned of the need to vaccinate at least 70% of the world's population to prevent new variants emerging that may prove resistant to the existing vaccines. \n</p>\n<p>\n  The news comes as Indonesia and Russia record daily death tolls, with Russian authorities reporting 737 more fatalities and a steep rise in new infections. Indonesia is sourcing oxygen from Singapore and calling on other countries to help as it counted a record 728 deaths in a single day, as AFP reported . \n</p>\n<p>\n  The prime minister of Luxembourg, Xavier Bettel, is in hospital suffering COVID symptoms, after testing positive and showing low oxygen levels in his blood, the Guardian reported. \"The prime minister's current medical condition is considered serious, but stable,\" the government said in a statement. \n</p>\n<p>\n</p>\n<p>\n  President Joe Biden is expected to speak later Tuesday on his administration's fight against the COVID-19 pandemic,  with the remarks coming after his administration fell short of his goal of having 70% of U.S. adults at least partially vaccinated by the Fourth of July. \n</p>\n<p>\n  Biden is due to speak at 2:45 p.m. Eastern in Washington about \"the COVID-19 response and the vaccination program,\" the White House said in a statement. \n</p>\n<p>\n  The percentage of U.S. adults who have received at least <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine dose stands at 67.1%, according to a Centers for Disease Control and Prevention tracker  vaccine has not been authorized for use in the U.S. \n</p>\n<p>\n  On Sunday, the president mixed the country's Independence Day party with a celebration of freedom from the worst of the pandemic, as he described getting vaccinated as \"the most patriotic thing you can do .\" \n</p>\n<p>\n  Meanwhile, pandemic restrictions on travel between the U.S. and neighboring Canada started to loosen on Monday for some Canadians, and Prime Minister Justin Trudeau said plans to totally reopen the border would be announced over the next few weeks, the Associated Press reported.   \n</p>\n<p>\n  Canadian citizens and permanent residents who have had a full dose of a coronavirus vaccine approved for use in Canada can skip a 14-day quarantine that has been a requirement since March 2020. Eligible air travelers also no longer have to spend their first three days in the country at a government-approved hotel. \n</p>\n<p>\n  Restrictions barring all non-essential trips between Canada and the United States, including tourism, will remain in place until at least July 21. \n</p>\n<p>\n  See also: Rising COVID-19 cases in California highlight risks of delta variant, as WHO head warns world in dangerous period of pandemic  \n</p>\n<p>\n  Latest tallies \n</p>\n<p>\n  The global tally for the coronavirus-borne illness headed above 184 million on Tuesday, according to data aggregated by Johns Hopkins University , while deaths climbed above 3.95 million. \n</p>\n<p>\n  The U.S. continues to lead the world in total cases at 33.7 million, and by deaths that total 605,567. \n</p>\n<p>\n  Don't miss: Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away  \n</p>\n<p>\n  India is second in total cases at 30.6 million and third by fatalities at 403,281. \n</p>\n<p>\n  Brazil has the third-highest caseload at 18.8 million, according to JHU data, and is second in deaths at 525,112. \n</p>\n<p>\n  Mexico has fourth-highest death toll at 233,689 and 2.5 million cases. \n</p>\n<p>\n  In Europe, Russia continues to pull ahead of the U.K. by deaths. Russia has 137,005 fatalities, while the U.K. has 128,495, making Russia the country with the fifth-highest death toll in the world and highest in Europe. \n</p>\n<p>\n  China, where the virus was first discovered late in 2019,  has had 103891 confirmed cases and 4,848 deaths, according to its official numbers, which are widely held to be massively underreported. \n</p>\n<p>\n  -Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  July 06, 2021 10:49 ET (14:49 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2149365690","content_text":"MW Israel says Pfizer vaccine just 64% effective in real world as delta variant continues to spread rapidly\n\n\n  Ciara Linnane \n\n\n  The global tally of confirmed cases of COVID-19 climbed above 184 million on Tuesday, as the highly transmissible delta variant continued to race across the world and the Israeli health ministry said it believes delta has weakened the overall effectiveness of its vaccine program. \n\n\n  Israel was an early success in the rush to vaccinate its residents but has fully vaccinated just 57% so far, according to Johns Hopkins University,  and has primarily used the vaccine developed by Pfizer and German partner BioNTech. That vaccine uses mRNA technology that is also used in the Moderna vaccine, both of which are authorized in the U.S. \n\n\n  The Israeli health ministry said it now believes the vaccine is just 64% effective at preventing symptomatic infections, which compares with the efficacy rate of about 95% in clinical trials back in 2020, it said in a statement posted on Twitter. The vaccine remains roughly 93% effective at preventing hospitalizations and death, the ministry said. Experts have repeatedly warned of the need to vaccinate at least 70% of the world's population to prevent new variants emerging that may prove resistant to the existing vaccines. \n\n\n  The news comes as Indonesia and Russia record daily death tolls, with Russian authorities reporting 737 more fatalities and a steep rise in new infections. Indonesia is sourcing oxygen from Singapore and calling on other countries to help as it counted a record 728 deaths in a single day, as AFP reported . \n\n\n  The prime minister of Luxembourg, Xavier Bettel, is in hospital suffering COVID symptoms, after testing positive and showing low oxygen levels in his blood, the Guardian reported. \"The prime minister's current medical condition is considered serious, but stable,\" the government said in a statement. \n\n\n\n\n  President Joe Biden is expected to speak later Tuesday on his administration's fight against the COVID-19 pandemic,  with the remarks coming after his administration fell short of his goal of having 70% of U.S. adults at least partially vaccinated by the Fourth of July. \n\n\n  Biden is due to speak at 2:45 p.m. Eastern in Washington about \"the COVID-19 response and the vaccination program,\" the White House said in a statement. \n\n\n  The percentage of U.S. adults who have received at least one vaccine dose stands at 67.1%, according to a Centers for Disease Control and Prevention tracker  vaccine has not been authorized for use in the U.S. \n\n\n  On Sunday, the president mixed the country's Independence Day party with a celebration of freedom from the worst of the pandemic, as he described getting vaccinated as \"the most patriotic thing you can do .\" \n\n\n  Meanwhile, pandemic restrictions on travel between the U.S. and neighboring Canada started to loosen on Monday for some Canadians, and Prime Minister Justin Trudeau said plans to totally reopen the border would be announced over the next few weeks, the Associated Press reported.   \n\n\n  Canadian citizens and permanent residents who have had a full dose of a coronavirus vaccine approved for use in Canada can skip a 14-day quarantine that has been a requirement since March 2020. Eligible air travelers also no longer have to spend their first three days in the country at a government-approved hotel. \n\n\n  Restrictions barring all non-essential trips between Canada and the United States, including tourism, will remain in place until at least July 21. \n\n\n  See also: Rising COVID-19 cases in California highlight risks of delta variant, as WHO head warns world in dangerous period of pandemic  \n\n\n  Latest tallies \n\n\n  The global tally for the coronavirus-borne illness headed above 184 million on Tuesday, according to data aggregated by Johns Hopkins University , while deaths climbed above 3.95 million. \n\n\n  The U.S. continues to lead the world in total cases at 33.7 million, and by deaths that total 605,567. \n\n\n  Don't miss: Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push -- but it could still be months away  \n\n\n  India is second in total cases at 30.6 million and third by fatalities at 403,281. \n\n\n  Brazil has the third-highest caseload at 18.8 million, according to JHU data, and is second in deaths at 525,112. \n\n\n  Mexico has fourth-highest death toll at 233,689 and 2.5 million cases. \n\n\n  In Europe, Russia continues to pull ahead of the U.K. by deaths. Russia has 137,005 fatalities, while the U.K. has 128,495, making Russia the country with the fifth-highest death toll in the world and highest in Europe. \n\n\n  China, where the virus was first discovered late in 2019,  has had 103891 confirmed cases and 4,848 deaths, according to its official numbers, which are widely held to be massively underreported. \n\n\n  -Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  July 06, 2021 10:49 ET (14:49 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125394268,"gmtCreate":1624648689954,"gmtModify":1703842774161,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125394268","repostId":"1119853713","repostType":4,"repost":{"id":"1119853713","pubTimestamp":1624631902,"share":"https://ttm.financial/m/news/1119853713?lang=&edition=fundamental","pubTime":"2021-06-25 22:38","market":"us","language":"en","title":"Netflix Rises as Credit Suisse Sees Subscriber Growth Normalizing","url":"https://stock-news.laohu8.com/highlight/detail?id=1119853713","media":"The Street","summary":"Netflix was upgraded to outperform with a $586 price target at Credit Suisse, which expects subscrib","content":"<blockquote>\n Netflix was upgraded to outperform with a $586 price target at Credit Suisse, which expects subscriber growth to normalize.\n</blockquote>\n<p>Shares of Netflix&nbsp;(<b>NFLX</b>) were higher on Friday after the video-streaming service was upgraded to outperform from neutral by analysts at Credit Suisse.</p>\n<p>The investment firm's analysts say they expect subscriber growth to normalize in the fourth quarter. A survey by the firm among U.S. customers reinforced the platform's competitive position and high user satisfaction, CS said.</p>\n<p><b>Jon Markman on Real Money Picks Stocks for the Digital Future</b></p>\n<p>Analysts maintained their $586 price target while saying the stock is at a favorable entry point and attractive absolute valuation.</p>\n<p>The firm sees a strong August to December pipeline on releases with \"numerous potential top-of-funnel titles,\" according to analyst Douglas Mitchelson. He also expects a stronger full-year slate in 2022 vs 2021.</p>\n<p>Second-quarter results and third-quarter guidance are still uncertain and any disappointment could be a \"clearing event\" ahead of a rebound in the fourth quarter, according to Mitchelson.</p>\n<p>Shares of Netflix at last check were 1.7% higher $527.14.</p>\n<p><img src=\"https://static.tigerbbs.com/abf3270957252db3a40ff3b8f395e66d\" tg-width=\"712\" tg-height=\"530\"></p>\n<p>Earlier this month, Netflix and&nbsp;Amblin Partners, the film and television studio led by Steven Spielberg, raised the curtain ona partnership.&nbsp;In the deal, the Hollywood director's company will produce multiple films a year for the Los Gatos, Calif., streaming giant.</p>\n<p>Spielberg, the Oscar-winning director of \"Schindler's&nbsp;List,\" \"Jurassic Park\" and \"Saving Private Ryan,\" will continue to direct movies for Comcast's&nbsp;(<b>CMCSA</b>) -Get ReportUniversal Pictures as part of a separate deal.</p>\n<p>Earlier this month, Netflix launched Netflix.shop, whichwill sell curatedproducts including apparel, toys and games.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Rises as Credit Suisse Sees Subscriber Growth Normalizing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Rises as Credit Suisse Sees Subscriber Growth Normalizing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 22:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/netflix-climbs-on-credit-suisse-upgrade-to-outperform><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Netflix was upgraded to outperform with a $586 price target at Credit Suisse, which expects subscriber growth to normalize.\n\nShares of Netflix (NFLX) were higher on Friday after the video-streaming ...</p>\n\n<a href=\"https://www.thestreet.com/investing/netflix-climbs-on-credit-suisse-upgrade-to-outperform\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://www.thestreet.com/investing/netflix-climbs-on-credit-suisse-upgrade-to-outperform","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119853713","content_text":"Netflix was upgraded to outperform with a $586 price target at Credit Suisse, which expects subscriber growth to normalize.\n\nShares of Netflix (NFLX) were higher on Friday after the video-streaming service was upgraded to outperform from neutral by analysts at Credit Suisse.\nThe investment firm's analysts say they expect subscriber growth to normalize in the fourth quarter. A survey by the firm among U.S. customers reinforced the platform's competitive position and high user satisfaction, CS said.\nJon Markman on Real Money Picks Stocks for the Digital Future\nAnalysts maintained their $586 price target while saying the stock is at a favorable entry point and attractive absolute valuation.\nThe firm sees a strong August to December pipeline on releases with \"numerous potential top-of-funnel titles,\" according to analyst Douglas Mitchelson. He also expects a stronger full-year slate in 2022 vs 2021.\nSecond-quarter results and third-quarter guidance are still uncertain and any disappointment could be a \"clearing event\" ahead of a rebound in the fourth quarter, according to Mitchelson.\nShares of Netflix at last check were 1.7% higher $527.14.\n\nEarlier this month, Netflix and Amblin Partners, the film and television studio led by Steven Spielberg, raised the curtain ona partnership. In the deal, the Hollywood director's company will produce multiple films a year for the Los Gatos, Calif., streaming giant.\nSpielberg, the Oscar-winning director of \"Schindler's List,\" \"Jurassic Park\" and \"Saving Private Ryan,\" will continue to direct movies for Comcast's (CMCSA) -Get ReportUniversal Pictures as part of a separate deal.\nEarlier this month, Netflix launched Netflix.shop, whichwill sell curatedproducts including apparel, toys and games.","news_type":1},"isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125920635,"gmtCreate":1624642080527,"gmtModify":1703842689295,"author":{"id":"4087620081913390","authorId":"4087620081913390","name":"mignificent","avatar":"https://static.tigerbbs.com/a614969ad8e742dc33fca63bc0d8de94","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087620081913390","authorIdStr":"4087620081913390"},"themes":[],"htmlText":"RPA stock","listText":"RPA stock","text":"RPA stock","images":[{"img":"https://static.tigerbbs.com/7fae4adbc9a0d9a4db0818c99a19a836","width":"1080","height":"3429"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125920635","isVote":1,"tweetType":1,"viewCount":91,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}